State Street Corp Harrow Health, Inc. Transaction History

State Street Corp

$2.21 Trillion
Q1 2024

A detailed history of State Street Corp transactions in Harrow Health, Inc. stock. As of the latest transaction made, State Street Corp holds 635,372 shares of HROW stock, worth $11.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

635,372

Previous 618,040 2.8%

Holding current value

$11.4 Million

Previous $6.92 Million 21.42%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$9.3 - $13.23 $161,187 - $229,302	17,332 Added 2.8%	635,372 $8.41 Million
Q4 2023 Feb 14, 2024	SELL	$8.1 - $16.36 $572,078 - $1.16 Million	-70,627 Reduced 10.26%	618,040 $6.92 Million
Q3 2023 Nov 14, 2023	BUY	$14.03 - $22.08 $1.47 Million - $2.31 Million	104,794 Added 17.95%	688,667 $9.9 Million
Q2 2023 Aug 14, 2023	BUY	$17.37 - $28.08 $8.44 Million - $13.6 Million	485,860 Added 495.71%	583,873 $11.1 Million
Q1 2023 May 15, 2023	BUY	$13.84 - $21.46 $155,008 - $240,352	11,200 Added 12.9%	98,013 $2.07 Million

Q1 2022 May 16, 2022	BUY	$6.77 - $8.66 $30,607 - $39,151	4,521 Added 5.49%	86,813 $592,000
Q3 2021 Nov 15, 2021	BUY	$6.99 - $10.6 $87,375 - $132,500	12,500 Added 17.91%	82,292 $748,000
Q2 2021 Aug 16, 2021	SELL	$6.68 - $11.07 $1.86 Million - $3.08 Million	-278,631 Reduced 79.97%	69,792 $648,000
Q1 2021 May 17, 2021	SELL	$6.26 - $11.03 $901 - $1,588	-144 Reduced 0.04%	348,423 $2.35 Million
Q4 2020 Feb 16, 2021	BUY	$4.76 - $6.93 $404,604 - $589,056	85,001 Added 32.25%	348,567 $2.39 Million
Q3 2020 Nov 10, 2020	BUY	$4.71 - $7.36 $39,578 - $61,846	8,403 Added 3.29%	263,566 $1.47 Million
Q2 2020 Aug 14, 2020	BUY	$3.61 - $6.47 $921,138 - $1.65 Million	255,163 New	255,163 $1.33 Million

Others Institutions Holding HROW

# of Institutions

123

Shares Held

21.3M

Call Options Held

113K

Put Options Held

366K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $486M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Harrow Health, Inc. Transaction History